Since glutathione synthesis requires cysteine and related amino acids, reduced protein intake observed during GLP-1RA therapy [75] may influence both antioxidant buffering capacity and anabolic maintenance
Most patients reach effective appetite suppression between 0.51.0 mg weekly, though some benefit from higher doses under medical supervision
Most symptoms resolve within 2-4 weeks as your body adjusts, but knowing what to expect and how to manage discomfort keeps you on track with treatment
And lower OXT levels were correlated to higher insulin levels, HOMA-IR and HbA1c levels in T2DM patients [108]
This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications